New molecular marker in AML: DNA-fingerprint differences between leukemic phase and remission in acute myeloid leukemia.

Pakkala, S; Helminen, P; Ruutu, T; Saarinen, U M; Peltonen, L

Pakkala, S; Helminen, P; Ruutu, T; Saarinen, U M; Peltonen, L.

Affiliation

Pakkala S; Transplantation Laboratory, University of Helsinki, Finland.

Leuk Res ; 13(10): 907-13, 1989.

Article in En | MEDLINE | ID: mdl-2573752

Subject(s)

Biomarkers, Tumor; DNA, Neoplasm/genetics; Leukemia, Myeloid, Acute/diagnosis; Blotting, Southern; DNA Probes; Humans; Leukemia, Myeloid, Acute/genetics; Polymorphism, Restriction Fragment Length

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: DNA, Neoplasm / Leukemia, Myeloid, Acute / Biomarkers, Tumor Type of study: Prognostic_studies Limits: Humans Language: En Journal: Leuk Res Year: 1989 Type: Article Affiliation country: Finland

Search on Google

XML

PubMed Links